Hazlett, Burt & Watson’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Hazlett, Burt & Watson's AZN Position: Q3 2026 in Review
Hazlett, Burt & Watson increased its AstraZeneca (AZN) stake by 0.63% in Q3 2026, buying an estimated $1.17K and bringing the position to 1,114 shares worth $180K. The position accounts for 0.05% of the portfolio, ranked #275.
Hazlett, Burt & Watson first reported a position in AZN in Q1 2022 and has held it in 19 quarters since. The position peaked at $212K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Hazlett, Burt & Watson held 1,114 shares of AstraZeneca worth $180K as of Q3 2026.
- Hazlett, Burt & Watson bought 7 AstraZeneca shares in Q3 2026, an estimated $1.17K.
- AstraZeneca made up 0.05% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #275 holding.
- Hazlett, Burt & Watson first reported a position in AstraZeneca in Q1 2022 and has held it in 19 quarters since.
- Hazlett, Burt & Watson's AstraZeneca position peaked at $212K in Q1 2026.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.